Pharma’s return to growth: EvaluatePharma

On 26 June, EvaluatePharma released their “World Preview: 2013” report which forecasts a return to return to growth of the global biopharma market – in contrast to their prediction of unprecedented market contraction in the 2012 report.  It seems that we … Continue reading

Companies and products making the greatest contributions to Cardiology: as rated by cardiologists

In a recent Sermo survey (Contributions to Cardiology: Healthcare Companies and Products – FiercePharma), 100 cardiologists were asked their opinions on the top 3 companies in terms of commitment to cardiology, and the top 3 prescription products which have yielded the … Continue reading